Javelin Pharmaceuticals Inc (JAV)

[rfj1862]

>The further it goes down the harder you have to consider the alternative that all isn't as it seems to be.<

Write the company and ask them what they've disclosed to major shareholders that they have not disclosed to us.

The real issue here for long-term shareholders isn't where the price is now, it's where it is when Javelin has to raise more cash, which should be late next year.

Agitate a little...after all, you do own part of this company, and the people below work for you.

Would suggest copying senior management on any messages to Ricky.

**************************************************************

Daniel B. Carr, MD
Chief Executive Officer & Chief Medical Officer
[e-mail]

Fred H. Mermelstein, Ph.D.
President
[e-mail]

Stephen J. Tulipano, CPA, MBA
Chief Financial Officer
[e-mail]

Michael T. Sheckler, MBA
VP, Business Development
[e-mail]

June C. Gregg
Corporate Communications
[e-mail]

Frederick "Rick" E. Pierce, II
VP, Investor Relations
[e-mail]